During the past decade, Jiangxi Provincial People's Hospital conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 2 clinical trials were completed, i.e. on average, 4.8% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jiangxi Provincial People's Hospital" #1 sponsor was "Pfizer" with 5 trials, followed by "Bayer" with 3 trials sponsored, "Capital Medical University" with 3 trials sponsored, "TaiGen Biotechnology Co., Ltd." with 3 trials sponsored and "Beijing Tiantan Hospital" with 3 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jiangxi Provincial People's Hospital" #1 collaborator was "Jiangxi Provincial People's Hopital" with 6 trials as a collaborator, "First Affiliated Hospital Xi'an Jiaotong University" with 4 trials as a collaborator, "First Affiliated Hospital of Harbin Medical University" with 4 trials as a collaborator, "First Hospital of China Medical University" with 4 trials as a collaborator and "Qilu Hospital of Shandong University" with 4 trials as a collaborator. Other collaborators include 345 different institutions and companies that were collaborators in the rest 255 trials.

According to Clinical.Site data, the most researched conditions in "Jiangxi Provincial People's Hospital" are "Hemophilia A" (7 trials), "Adverse Drug Reaction" (2 trials), "Community-acquired Pneumonia" (2 trials), "Coronary Artery Disease" (2 trials) and "Coronary Heart Disease" (2 trials). Many other conditions were trialed in "Jiangxi Provincial People's Hospital" in a lesser frequency.

Most popular intervention types in "Jiangxi Provincial People's Hospital" are "Drug" (34 trials), "Device" (4 trials), "Biological" (3 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection" (2 trials), "Zavicefta, Ceftazidime-Avibactam" (2 trials), "parsaclisib" (2 trials) and "placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Jiangxi Provincial People's Hospital" are 44 trials for "All" genders, 5 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Jiangxi Provincial People's Hospital". 2 are not yet recruiting, 17 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Jiangxi Provincial People's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jiangxi Provincial People's Hospital, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 5 trials that are defined as “Not Applicable".